The Effects of Keeping the Patient in a Sitting Position for One Minute After Spinal Anesthesia

NCT ID: NCT03834259

Last Updated: 2019-02-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

214 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-01

Study Completion Date

2017-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to examine the effect of keeping the patient in a sitting position for 1 minute after spinal anaesthesia in elective caesarean operations, primarily on the formation of hypotension and secondarily on nausea-vomiting, the need for ephedrine and the block characteristics.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypotension Spinal Anaesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

12.5 mg 0.5% hyperbaric bupivacaine

Group Type ACTIVE_COMPARATOR

sitting position

Intervention Type PROCEDURE

keeping the patient in a sitting position after spinal anaesthesia

Group 2

10 mg 0.5% hyperbaric bupivacaine

Group Type ACTIVE_COMPARATOR

supine position

Intervention Type PROCEDURE

keeping the patient in supine position after spinal anaesthesia

Group 3

12.5 mg 0.5% hyperbaric bupivacaine

Group Type ACTIVE_COMPARATOR

supine position

Intervention Type PROCEDURE

keeping the patient in supine position after spinal anaesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sitting position

keeping the patient in a sitting position after spinal anaesthesia

Intervention Type PROCEDURE

supine position

keeping the patient in supine position after spinal anaesthesia

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged 18 - 45 years,
* ASA physical status
* I - II,
* BMI of 25-30
* who were undergoing elective CS

Exclusion Criteria

* vertebral anomaly,
* peripheral vascular disease,
* cardiovascular or psychiatric disorder,
* severe anemia,
* coagulopathy
* infection in the intervention region
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Umraniye Education and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gulsah Karaoren

associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GK12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ephedrine and Phenylephrine for Spinal Hypotension
NCT03047109 COMPLETED PHASE2/PHASE3
Role of Ondansetron in Spinal Anaesthesia Induced Hypotension
NCT06727201 NOT_YET_RECRUITING PHASE2/PHASE3